Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
---|
CEO | Mr. Joseph Michael Burnett |
IPO Date | May 22, 2012 |
Location | United States |
Headquarters | 120 S. Sierra Avenue |
Employees | 107 |
Sector | Healthcare |
Industries |
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Past 5 years
USD 11.69
USD 13.76
USD 2.80
USD 34.04
USD 2.64
USD 193.50
USD 9.10
USD 49.95
USD 34.40
USD 1.44
USD 79.67
USD 24.00
USD 10.05
USD 5.68
StockViz Staff
February 3, 2025
Any question? Send us an email